Bloomberg Law
Free Newsletter Sign Up
Bloomberg Law
Welcome
Go
Free Newsletter Sign Up

Acella Thyroid Drug Delivered Incorrect Doses, Class Suit Says

May 13, 2022, 8:27 PM

Thyroid patients spent money on “worthless” Acella Pharmaceuticals LLC thyroid medication that contained too much or too little of its active ingredient, a consumer says in a proposed nationwide class suit.

Sue Faulkner also asserts an individual claim that she experienced painful and debilitating symptoms of hypothyroidism while taking Acella’s NP Thyroid pills from batches that were later recalled. Her complaint was filed Thursday in the US District Court for the Northern District of Georgia.

The company didn’t file a New Drug Application with the US Food and Drug Administration before manufacturing and marketing NP Thyroid, a violation of federal ...